Literature DB >> 15180803

The relapse rate of multiple sclerosis changes during pregnancy: a cohort study.

G Salemi1, G Callari, M Gammino, F Battaglieri, E Cammarata, G Cuccia, M D'Amelio, I Lupo, P Ragonese, G Savettieri.   

Abstract

OBJECTIVE: To evaluate the influence of pregnancy and puerperium on the relapse rate of multiple sclerosis (MS).
METHODS: We determined retrospectively the yearly mean relapse rate (MRR) during pregnancies occurring in the course of relapsing-remitting MS. We compared the MRR of pregnancy-time with that of non-pregnancy time by paired t-test. Relative risk (RR) of relapses during the pregnancy-time was also compared with that of non-pregnancy time by chi(2) analysis and 95% confidence intervals.
RESULTS: From a population of 351 women affected by clinically definite MS, only 70 reported pregnancies during their relapsing-remitting phase of MS for a total of 98 pregnancies. Both MRR (P = 0.006) and RR (RR = 0.63, 95% CI = 0.40-0.94) decreased during the three trimesters of pregnancy. RR increased in the first 3 months of puerperium, although this was not statistically significant (RR = 1.36, 95% CI = 0.79-2.20).
CONCLUSION: Our study confirms that in MS the relapse rate decreases throughout pregnancy and increases during puerperium. This suggests a complex interplay between hormonal and immune factors.

Entities:  

Mesh:

Year:  2004        PMID: 15180803     DOI: 10.1111/j.1600-0404.2004.00270.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  13 in total

1.  Lower brain diffusivity in postpartum period compared to late pregnancy: results from a prospective imaging study of multiple sclerosis patients.

Authors:  Teemu Paavilainen; Timo Kurki; Markus Färkkilä; Oili Salonen; Riitta Parkkola; Laura Airas
Journal:  Neuroradiology       Date:  2011-12-13       Impact factor: 2.804

Review 2.  Multiple sclerosis and pregnancy in the 'treatment era'.

Authors:  Sandra Vukusic; Romain Marignier
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

3.  Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis.

Authors:  Carol Aristimuño; Roseta Teijeiro; Lara Valor; Bárbara Alonso; Marta Tejera-Alhambra; Clara de Andrés; Desamparados Oliver Miñarro; Nieves López-Lazareno; Florence Faure; Silvia Sánchez-Ramón
Journal:  Clin Exp Med       Date:  2012-01-07       Impact factor: 3.984

Review 4.  New approaches in the management of multiple sclerosis.

Authors:  Laurie J Barten; Douglas R Allington; Kendra A Procacci; Michael P Rivey
Journal:  Drug Des Devel Ther       Date:  2010-11-24       Impact factor: 4.162

Review 5.  [Pregnancy and immunomodulatory therapy in multiple sclerosis patients].

Authors:  L A Hoffmann; T Kümpfel; I Heer; R Hohlfeld
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 6.  T helper cell immunity in pregnancy and influence on autoimmune disease progression.

Authors:  Jonathon J Graham; Maria Serena Longhi; Michael A Heneghan
Journal:  J Autoimmun       Date:  2021-05-18       Impact factor: 7.094

7.  Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.

Authors:  Nadja Borisow; Andrea Döring; Caspar F Pfueller; Friedemann Paul; Jan Dörr; Kerstin Hellwig
Journal:  EPMA J       Date:  2012-06-22       Impact factor: 6.543

8.  Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study.

Authors:  Jawad Fares; Anwar H Nassar; Souheil Gebeily; Firas Kobeissy; Youssef Fares
Journal:  BMJ Open       Date:  2016-05-13       Impact factor: 2.692

9.  Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS.

Authors:  Maria K Houtchens; Natalie C Edwards; Amy L Phillips
Journal:  Neurology       Date:  2018-09-28       Impact factor: 9.910

10.  Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations.

Authors:  Beatriz Canibaño; Dirk Deleu; Boulenouar Mesraoua; Gayane Melikyan; Faiza Ibrahim; Yolande Hanssens
Journal:  J Drug Assess       Date:  2020-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.